Browse medicines, page 7 of 49

Use listed on the medicine record

INDICATIONS & USAGE Heparin sodium injection is indicated for: • Prophylaxis and treatment of venous thrombosis and pulmonary embolism; • Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; • Atrial fibrillation with embolization; • Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); • Prevention of clotting in arterial and cardiac surgery; • Prophylaxis and treatment of peripheral arterial…

Use listed on the medicine record

Regul Oil Cleansing Cream indications

Use listed on the medicine record

Lymphangioleiomyomatosis ( 1

Use listed on the medicine record

Hypertension

Use listed on the medicine record

Symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered

Use listed on the medicine record

Profuse watery diarrhea associated with VIP-secreting tumors

Use listed on the medicine record

Postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors

Use listed on the medicine record

Topical treatment of mild to moderate atopic dermatitis

Use listed on the medicine record

R-Gene ® 10 is indicated as an intravenous stimulant to the pituitary for the release of human growth hormone in patients where the measurement of pituitary reserve for HGH can be of diagnostic usefulness. It can be used as a diagnostic aid in such conditions as panhypopituitarism, pituitary dwarfism, chromophobe adenoma, postsurgical craniopharyngioma, hypophysectomy, pituitary trauma, acromegaly, gigantism and problems of growth and stature.

Use listed on the medicine record

When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.

Use listed on the medicine record

Moderately to severely active rheumatoid arthritis

Use listed on the medicine record

【Energized Skin with Enhanced Elasticity】:Caffeine stimulates mcirculation to firm and tighten the skin. By energizing the dermal layers, it supports collagen production, visibly lifting sagging areas and delivering a refreshed, sculpted appearance. 【Hydration Redefined for Lasting Glow】:Hyaluronic acid, known for its exceptional moisture-retention properties, replenishes hydration deep within the skin, plumping its surface for a smooth, dewy finish. Collagen reinforces the skin’s structural matrix, improving elasticity and helping retain hydration for a luminous, healthy glow.

Use listed on the medicine record

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with • Metastatic castration-resistant prostate cancer (CRPC) • Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with • metastatic castration-resistant prostate cancer (CRPC). ( 1 ) • metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )

Use listed on the medicine record

DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). ( 1 )

Use listed on the medicine record

Common migraine headache

Use listed on the medicine record

Temporarily restore mental alertness and refresh mental state for fatigue or drowsiness.

Use listed on the medicine record

Moderate to severe plaque psoriasis

Use listed on the medicine record

Corneal cystine crystal deposits

Use listed on the medicine record

Locally advanced or metastatic breast cancer after failure of prior chemotherapy

Use listed on the medicine record

Treatment of acute attacks of hereditary angioedema

Use listed on the medicine record

Muscle strength

Use listed on the medicine record

Eptifibatide injection is a platelet aggregation inhibitor indicated for: • Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI) ( 1.1 ) • Treatment of patients undergoing PCI (including intracoronary stenting) ( 1.2 ) 1.1 Acute Coronary Syndrome (ACS) Eptifibatide injection is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstable angina [UA]/non-ST- elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those undergoing…

Use listed on the medicine record

Diabetic ketoacidosis

Use listed on the medicine record

The following autoinflammatory Periodic Fever Syndromes

Use listed on the medicine record

Elevated serum cholesterol

Use listed on the medicine record

Partial-onset seizures

Use listed on the medicine record

Locally confined carcinoma of the prostate ( 1

Use listed on the medicine record

The medical rather than the elective induction of labor

Use listed on the medicine record

These highlights do not include all the information needed to use VALPROIC ACID CAPSULES safely and effectively. See full prescribing information for VALPROIC ACID CAPSULES. VALPROIC ACID capsules for oral use Initial U.S. Approval: 1978 WARNING: LIFE THREATENING ADVERSE REACTIONS SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING. Hepatotoxicity, including fatalities, usually during the first 6 months of treatment. Children under the age of two years and patients with mitochondrial disorders are at higher risk.

Use listed on the medicine record

Severe chronic pain

Use listed on the medicine record

The prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are

Use listed on the medicine record

Neonatal-Onset Multisystem Inflammatory Disease

Use listed on the medicine record

Adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC) [see Clinical Studies (14

Use listed on the medicine record

Discontinue use and consult a doctor if This product, used as directed does not provide relief You or your partner develops a rash or irritation, such as burning or itching Condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days The following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue colored skin as these may be signs of methemoglobinemia, a rare disorder which may appear up to 2 hours of use Warnings DO NOT use if allergic to Benzocaine or any other ingredient in this product If swallowed…

Use listed on the medicine record

Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic

Use listed on the medicine record

Hypertension

Use listed on the medicine record

The inhibition of premature LH surges

Use listed on the medicine record

Postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors fo

Use listed on the medicine record

High-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy

Use listed on the medicine record

Resectable (tumors ≥ 4 cm and/or node positive) non-small cell lung cancer (NSCLC) and no known epidermal growth factor

Use listed on the medicine record

Section INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Etodolac extended-release tablets are indicated: * For relief of signs and symptoms of juvenile arthritis * For relief of the signs and symptoms of rheumatoid arthritis * For relief of the signs and symptoms of osteoarthritis

Use listed on the medicine record

The signs and symptoms of rheumatoid arthritis and osteoarthritis

Use listed on the medicine record

Unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tu

Use listed on the medicine record

Anorexia, cachexia, or an unexplained significant weight loss

Use listed on the medicine record

BAFIERTAM is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BAFIERTAM is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Use listed on the medicine record

Allergic reactions (Type I), including anaphylaxis, that may occur with accidental exposure to one or more foods

Use listed on the medicine record

XtraCare® Creamy Petroleum Jelly Cocoa Butter enriched Skin Protector Dry Skin Relief Rich Creamy Moisturiser *Compare to the active ingredient in Vaseline® Petroleum Jelly Cream Net Wt 4.5oz (127g) Xtracare® XtraCare Creamy Petroleum Jelly is specially formulated to moisturize, soften and soothe dry skin. Blended with Coco butter oil to product a rich creamy moisturizer. Use on hands, knees, feet and heels to smooth away dryness. Great for moisturizing face and neck.

Use listed on the medicine record

Severe asthma aged 18 years and older with an eosinophilic phenotype

Use listed on the medicine record

Multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative

Use listed on the medicine record

Acute heart failure to reduce, left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance

Use listed on the medicine record

Nutrilipid ® 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated. Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated. ( 1 )

Use listed on the medicine record

Metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET ) exon 14 skipping alterations

Use listed on the medicine record

Blood pressure

Use listed on the medicine record

Amiodarone Hydrochloride Injection, USP is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. Amiodarone Hydrochloride Injection, USP also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with Amiodarone Hydrochloride Injection, USP patients may be transferred to oral amiodarone therapy [see Dosage and Administration ( 2 )] .

Use listed on the medicine record

Metastatic NSCLC who have disease progression during or following platinum-containing chemotherapy